NCT03003650View on ClinicalTrials.gov

ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis:CE-approval Cohort

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

August 31, 2017

Conditions
Symptomatic Aortic Stenosis
Interventions
DEVICE

ACURATE TF™

ACURATE TF™Transfemoral Aortic Bioprosthesis is intended for subjects with severe symptomatic Aortic Stenosis and are considered high risk for surgical conventional Aortic Valve Replacement .

Trial Locations (6)

20246

Universitäres Herzzentrum Hamburg, Hamburg

50937

Herzzentrum Universitätsklinikum Köln, Cologne

53105

Universitätsklinikum Bonn, Bonn

61231

Kerckhoff Klinik GmbH, Bad Nauheim

CEP 04012-909

Instituto Dante Pazzanese de Cardiologia, São Paulo

Unknown

Osaka University Hospital, Osaka

All Listed Sponsors
lead

Symetis SA

INDUSTRY

NCT03003650 - ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis:CE-approval Cohort | Biotech Hunter | Biotech Hunter